title: Adapting a community-based ART delivery model to the patients' needs: a mixed methods research in Tete, Mozambique.
abstract: BACKGROUND
  To improve retention in antiretroviral therapy (ART), lessons learned from chronic disease care were applied to HIV care, providing more responsibilities to patients in the care of their chronic disease. In Tete--Mozambique, patients stable on ART participate in the ART provision and peer support through Community ART Groups (CAG). This article analyses the evolution of the CAG-model during its implementation process.
  
  
  METHODS
  A mixed method approach was used, triangulating qualitative and quantitative findings. The qualitative data were collected through semi-structured focus groups discussions and in-depth interviews. An inductive qualitative content analysis was applied to condense and categorise the data in broader themes. Health outcomes, patients' and groups' characteristics were calculated using routine collected data. We applied an 'input--process--output' pathway to compare the initial planned activities with the current findings.
  
  
  RESULTS
  Input wise, the counsellors were considered key to form and monitor the groups. In the process, the main modifications found were the progressive adaptations of the daily CAG functioning and the eligibility criteria according to the patients' needs. Beside the anticipated outputs, i.e. cost and time saving benefits and improved treatment outcomes, the model offered a mutual adherence support and protective environment to the members. The active patient involvement in several health activities in the clinics and the community resulted in a better HIV awareness, decreased stigma, improved health seeking behaviour and better quality of care.
  
  
  CONCLUSIONS
  Over the past four years, the modifications in the CAG-model contributed to a patient empowerment and better treatment outcomes. One of the main outstanding questions is how this model will evolve in the future. Close monitoring is essential to ensure quality of care and to maintain the core objective of the CAG-model 'facilitating access to ART care' in a cost and time saving manner.
authors.affiliation: Departement of Public Health, Institute of Tropical Medicine, Nationale straat 155, Antwerp 2000, Belgium. frasschaert@itg.be.
authors.forename: Freya
authors.initials: F
authors.lastname: Rasschaert
authors.forename: Tom
authors.initials: T
authors.lastname: Decroo
authors.forename: Daniel
authors.initials: D
authors.lastname: Remartinez
authors.forename: Barbara
authors.initials: B
authors.lastname: Telfer
authors.forename: Faustino
authors.initials: F
authors.lastname: Lessitala
authors.forename: Marc
authors.initials: M
authors.lastname: Biot
authors.forename: Baltazar
authors.initials: B
authors.lastname: Candrinho
authors.forename: Wim
authors.initials: W
authors.lastname: Van Damme
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D003153:Community Health Services / Q000458:organization & administration*; D003376:Counseling; D005260:Female; D017144:Focus Groups; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D008875:Middle Aged; D008962:Models, Theoretical; D009073:Mozambique; D010342:Patient Acceptance of Health Care; D010358:Patient Participation; D036301:Qualitative Research
chemical_list: D044966:Anti-Retroviral Agents
references.citation: Prim Care. 2012 Dec;39(4):649-60
references.pmid: 23148958
references.citation: J Int AIDS Soc. 2009 May 06;12:6
references.pmid: 19419543
references.citation: Trop Med Int Health. 2009 Feb;14(2):190-5
references.pmid: 19207175
references.citation: Trop Med Int Health. 2010 Jun;15 Suppl 1:48-54
references.pmid: 20586960
references.citation: J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):e39-44
references.pmid: 21084990
references.citation: BMC Health Serv Res. 2012 Jul 09;12:194
references.pmid: 22776682
references.citation: J Acquir Immune Defic Syndr. 2010 Dec;55(4):483-90
references.pmid: 20683336
references.citation: J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):71-6
references.pmid: 17031319
references.citation: PLoS One. 2012;7(7):e40902
references.pmid: 22815862
references.citation: PLoS One. 2013;8(2):e56088
references.pmid: 23418518
references.citation: PLoS One. 2014 Mar 20;9(3):e91544
references.pmid: 24651523
references.citation: J Trop Med. 2012;2012:349312
references.pmid: 23209477
references.citation: BMJ. 1995 Jul 1;311(6996):42-5
references.pmid: 7613329
references.citation: J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):e33-9
references.pmid: 21372723
references.citation: Trop Med Int Health. 2010 Jun;15 Suppl 1:70-5
references.pmid: 20586963
references.citation: Soc Sci Med. 2002 Sep;55(6):991-1003
references.pmid: 12220099
references.citation: AIDS Care. 2009 Oct;21(10):1321-34
references.pmid: 20024709
references.citation: Soc Sci Med. 2007 Mar;64(6):1297-310
references.pmid: 17174016
references.citation: Int Health. 2009 Sep;1(1):97-101
references.pmid: 24036299
references.citation: Health Aff (Millwood). 2012 Jan;31(1):130-9
references.pmid: 22232103
references.citation: Trop Med Int Health. 2010 Jun;15 Suppl 1:1-15
references.pmid: 20586956
references.citation: J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S163-6
references.pmid: 12562043
references.citation: BMJ. 2000 Jan 8;320(7227):114-6
references.pmid: 10625273
references.citation: AIDS Res Treat. 2012;2012:749718
references.pmid: 22577527
references.citation: BMC Public Health. 2011 Aug 16;11:650
references.pmid: 21846344
references.citation: AIDS Patient Care STDS. 2009 Oct;23(10):867-75
references.pmid: 19803678
references.citation: Global Health. 2011 Oct 10;7:38
references.pmid: 21985187